These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17680241)

  • 1. Process optimization of large-scale production of recombinant adeno-associated vectors using dielectric spectroscopy.
    Negrete A; Esteban G; Kotin RM
    Appl Microbiol Biotechnol; 2007 Sep; 76(4):761-72. PubMed ID: 17680241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale production of recombinant adeno-associated viral vectors.
    Negrete A; Kotin RM
    Methods Mol Biol; 2008; 433():79-96. PubMed ID: 18679618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving adeno-associated vector yield in high density insect cell cultures.
    Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
    J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalable production of adeno-associated virus type 2 vectors via suspension transfection.
    Park JY; Lim BP; Lee K; Kim YG; Jo EC
    Biotechnol Bioeng; 2006 Jun; 94(3):416-30. PubMed ID: 16622883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a fed-batch culture strategy to enhance rAAV production in the baculovirus/insect cell system.
    Liu YK; Yang CJ; Liu CL; Shen CR; Shiau LD
    J Biosci Bioeng; 2010 Aug; 110(2):187-93. PubMed ID: 20547323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases.
    Galibert L; Merten OW
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S80-93. PubMed ID: 21784234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios.
    Aucoin MG; Perrier M; Kamen AA
    Biotechnol Bioeng; 2006 Dec; 95(6):1081-92. PubMed ID: 16952153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
    O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
    J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-amplification system for recombinant adeno-associated virus production.
    Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput production, screening and analysis of adeno-associated viral vectors.
    Drittanti L; Rivet C; Manceau P; Danos O; Vega M
    Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.
    Pillay S; Meyers A; Williamson AL; Rybicki EP
    Biotechnol Prog; 2009; 25(4):1153-60. PubMed ID: 19572400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system.
    Negrete A; Yang LC; Mendez AF; Levy JR; Kotin RM
    J Gene Med; 2007 Nov; 9(11):938-48. PubMed ID: 17764098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
    Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
    Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
    Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
    J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process.
    Thorne BA; Quigley P; Nichols G; Moore C; Pastor E; Price D; Ament JW; Takeya RK; Peluso RW
    Biologicals; 2008 Jan; 36(1):7-18. PubMed ID: 17644406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.
    Grimm D; Kern A; Pawlita M; Ferrari F; Samulski R; Kleinschmidt J
    Gene Ther; 1999 Jul; 6(7):1322-30. PubMed ID: 10455443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.